TEM vs UNH

Tempus AI Inc. continues to operate in the high-growth, AI-driven precision medicine sector with a vast TAM and a strong strategic vision, bolstered by its proprietary multi-modal data library and recent acquisitions like Ambry. Q1 2026 earnings showed a revenue beat and strong gross margin expansion (63.8%), with exceptional MRD volume growth (+500% YoY), affirming its market position. However, s...

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...